TY - JOUR
T1 - Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure
AU - Hayasaka, Kazuto
AU - Matsue, Yuya
AU - Kitai, Takeshi
AU - Okumura, Takahiro
AU - Kida, Keisuke
AU - Oishi, Shogo
AU - Akiyama, Eiichi
AU - Suzuki, Satoshi
AU - Yamamoto, Masayoshi
AU - Mizukami, Akira
AU - Yoshioka, Kenji
AU - Kuroda, Shunsuke
AU - Kagiyama, Nobuyuki
AU - Yamaguchi, Tetsuo
AU - Sasano, Tetsuo
N1 - Publisher Copyright:
© 2020 Published on behalf of the European Society of Cardiology. All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Aims: Not all worsening renal function (WRF) during heart failure treatment is associated with a poor prognosis. However, a metric capable providing a prognosis of relevant WRF has not been developed. Our aim was to evaluate if a change in tricuspid regurgitation pressure gradient (TRPG) could discriminate prognostically relevant and not relevant WRF in patients with acute heart failure (AHF). Methods and results: We examined 809 consecutive hospitalized patients with heart failure (78 ± 12 years, 54% male). WRF was defined as an increase in creatinine >0.3 mg and ≥25% from admission to discharge. TRPG was measured at admission and before discharge using echocardiography. The primary outcome was all-cause death within 1-year after discharge. Patients were classified as follows for analysis: no WRF and no TRPG increase (n = 523); no WRF and TRPG increase (no WRF with iTRPG, n = 170); WRF and no TRPG increase (WRF without iTRPG, n = 90); and WRF and TRPG increase (WRF with iTRPG, n = 26). A change in TRPG weakly but significantly correlated to a change in haemoglobin and haematocrit, a percent decrease in brain natriuretic peptide, and body weight reduction during the index period of hospitalization. All-cause mortality within 1 year was higher in patients with WRF and iTRPG, compared to the other three groups (P = 0.026). On Cox regression analysis, only WRF with iTRPG was associated with higher mortality (hazard ratio 4.24, P = 0.001), even after adjustment for other confounders. Conclusion: An increase in TRPG may provide a marker to identify prognostically relevant WRF in patients with AHF.
AB - Aims: Not all worsening renal function (WRF) during heart failure treatment is associated with a poor prognosis. However, a metric capable providing a prognosis of relevant WRF has not been developed. Our aim was to evaluate if a change in tricuspid regurgitation pressure gradient (TRPG) could discriminate prognostically relevant and not relevant WRF in patients with acute heart failure (AHF). Methods and results: We examined 809 consecutive hospitalized patients with heart failure (78 ± 12 years, 54% male). WRF was defined as an increase in creatinine >0.3 mg and ≥25% from admission to discharge. TRPG was measured at admission and before discharge using echocardiography. The primary outcome was all-cause death within 1-year after discharge. Patients were classified as follows for analysis: no WRF and no TRPG increase (n = 523); no WRF and TRPG increase (no WRF with iTRPG, n = 170); WRF and no TRPG increase (WRF without iTRPG, n = 90); and WRF and TRPG increase (WRF with iTRPG, n = 26). A change in TRPG weakly but significantly correlated to a change in haemoglobin and haematocrit, a percent decrease in brain natriuretic peptide, and body weight reduction during the index period of hospitalization. All-cause mortality within 1 year was higher in patients with WRF and iTRPG, compared to the other three groups (P = 0.026). On Cox regression analysis, only WRF with iTRPG was associated with higher mortality (hazard ratio 4.24, P = 0.001), even after adjustment for other confounders. Conclusion: An increase in TRPG may provide a marker to identify prognostically relevant WRF in patients with AHF.
KW - Acute heart failure
KW - Tricuspid regurgitation pressure gradient
KW - Worsening renal function
UR - https://www.scopus.com/pages/publications/85100359535
UR - https://www.scopus.com/pages/publications/85100359535#tab=citedBy
U2 - 10.1093/ehjci/jeaa035
DO - 10.1093/ehjci/jeaa035
M3 - Article
C2 - 32157273
AN - SCOPUS:85100359535
SN - 2047-2404
VL - 22
SP - 203
EP - 209
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 2
ER -